Artemis Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

Artemis Investment Management’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$629K	Buy	+15,319	New	+$556K	0.01%	210
2024 Q4	–	Sell	-120,000	Closed	-$1.18M	–	211
2024 Q3	$1.18M	Sell	120,000 -40,000	-25%	-$468K	0.02%	180
2024 Q2	$2.51M	Sell	160,000 -824,681	-84%	-$14.9M	0.03%	178
2024 Q1	$21.1M	Sell	984,681 -1,690,880	-63%	-$31.8M	0.27%	103
2023 Q4	$40.4M	Sell	2,675,561 -451,838	-14%	-$8.02M	0.58%	58
2023 Q3	$67.9M	Sell	3,127,399 -24,164	-0.8%	-$551K	0.95%	31
2023 Q2	$72.9M	Buy	+3,151,563	New	+$72.2M	0.91%	30

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Artemis Investment Management's INDV Position: Q2 2026 in Review

Artemis Investment Management opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 15,319 shares worth $629K. The stake represents 0.01% of the portfolio and ranks #210 among its holdings. This is a return to the name: Artemis Investment Management previously reported a position in INDV as recently as Q3 2024.

Artemis Investment Management first reported a position in INDV in Q2 2023 and has held it in 7 quarters since. The position peaked at $72.9M in Q2 2023. 49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Artemis Investment Management held 15,319 shares of Indivior Pharmaceuticals worth $629K as of Q2 2026.
Indivior Pharmaceuticals was a new Artemis Investment Management position in Q2 2026.
Indivior Pharmaceuticals made up 0.01% of Artemis Investment Management's portfolio in Q2 2026, its #210 holding.
Artemis Investment Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
Artemis Investment Management's Indivior Pharmaceuticals position peaked at $72.9M in Q2 2023.
49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.